These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10426361)

  • 1. Multiple sclerosis--emerging concepts of disease pathogenesis.
    Antel J
    J Neuroimmunol; 1999 Jul; 98(1):45-8. PubMed ID: 10426361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
    Minagar A; Toledo EG; Alexander JS; Kelley RE
    J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of multiple sclerosis: relating human pathology to experimental studies.
    Ludwin SK
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):305-18. PubMed ID: 16691112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.
    Wujek JR; Bjartmar C; Richer E; Ransohoff RM; Yu M; Tuohy VK; Trapp BD
    J Neuropathol Exp Neurol; 2002 Jan; 61(1):23-32. PubMed ID: 11829341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of tissue injury in MS lesions.
    Trapp BD; Bö L; Mörk S; Chang A
    J Neuroimmunol; 1999 Jul; 98(1):49-56. PubMed ID: 10426362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy.
    Minagar A; Maghzi AH; McGee JC; Alexander JS
    Neurol Res; 2012 Oct; 34(8):738-45. PubMed ID: 22828184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis.
    Zamvil SS; Steinman L
    Neuron; 2003 Jun; 38(5):685-8. PubMed ID: 12797954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remyelination in multiple sclerosis: a challenge for therapy. The 1996 European Charcot Foundation Lecture.
    Compston A
    Mult Scler; 1997 Apr; 3(2):51-70. PubMed ID: 9291155
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunity and neurodegeneration: new concepts in multiple sclerosis].
    Lalive PH; Schluep M; Chofflon M; Du Pasquier R
    Rev Med Suisse; 2006 May; 2(64):1166-8, 1170. PubMed ID: 16734188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic and imaging correlates of cognitive deficits in multiple sclerosis: changing the paradigm of diagnosis and prognosis.
    Shi J; Baxter LC; Kuniyoshi SM
    Cogn Behav Neurol; 2014 Mar; 27(1):1-7. PubMed ID: 24674960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathology of multiple sclerosis and its evolution.
    Lassmann H
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1635-40. PubMed ID: 10603616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Multiple Sclerosis 2017.
    Göbel K; Kleinschnitz C; Meuth SG
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in-vitro approach to the study of oligodendrocytes and their involvement in multiple sclerosis.
    Szuchet S; Dumas M
    Neurol Clin; 1983 Aug; 1(3):729-55. PubMed ID: 6680171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body fluid markers to monitor multiple sclerosis: the assays and the challenges.
    Laman JD; Thompson EJ; Kappos L
    Mult Scler; 1998 Jun; 4(3):266-9. PubMed ID: 9762687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
    Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis.
    Murray PD; McGavern DB; Sathornsumetee S; Rodriguez M
    Brain; 2001 Jul; 124(Pt 7):1403-16. PubMed ID: 11408335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current data on interferon therapy of multiple sclerosis in patients at developmental age].
    Smigielska-Kuzia J; Sobaniec W; Kułak W; Boćkowski L; Wołk M; Sołowiej E; Artemowicz B
    Neurol Neurochir Pol; 2004; 38(1 Suppl 1):S45-51. PubMed ID: 15045867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders.
    Kira J
    J Neurol Sci; 2011 Dec; 311(1-2):69-77. PubMed ID: 21962794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.
    Stuerzebecher S; Martin R
    Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis of multiple sclerosis and other neural autoimmune diseases].
    Lassmann H
    Verh Dtsch Ges Pathol; 1996; 80():109-15. PubMed ID: 9064993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.